ContentsIssue 109 • August 2021In association withIn association withThe impact of waiving vaccine patents Pressure is mounting on the pharmaceutical industry to waive patents on Covid-19 vaccinesIN DEPTHAlgae protein: a vision of tomorrowCommentContent management post MDRBriefingIndustry newsPharma industry briefingCovid-19 briefingCommentWill Early Access to Medicines speed up patient access to innovative drugs?The competitive landscape of neoantigen-targeting therapeutics in oncologyAn eco-friendly approach to chemical productionWill MDR transform content management?In DepthChickenpox vaccines in the UKFighting India’s ‘black fungus’ epidemicWhat could a vaccine patent waiver mean for pharma manufacturing?Algae proteins: a vision of the futureA brief history of ALS treatments Ferring chases a microbiome breakthroughIn DataDeals analysisPharma subsidiariesKey industry rankingsMarket data02/23/2024 23:27:11
Comment
Content management post MDR